SWOG clinical trial number
SWOG-7510

Adjuvant Chemotherapy for Patients with Locally Advanced Adenocarcinoma of the Large Bowel

Closed
Phase
Published
Abbreviated Title
Adjuvant Chemotherapy for Patients with Locally Advanced Adenocarcinoma of the Large Bowel
Activated
08/08/1975
Closed
08/20/1980

Publication Information Expand/Collapse

1994

With > 4,600 patient-years follow-up, SWOG colorectal adjuvant study suggests that BCG may act as a chemoprevention agent.

F Panettiere ASCO 13:171(#477)

1989

After resection of large bowel carcinoma, immune status is often depressed. Data from a SWOG study.

FJ Panettiere ASCO 8:107(#415)

1988

Adjuvant therapy in large bowel adenocarcinoma: Long term resultsof a Southwest Oncology Group Study.

FJ Panettiere;PJ Goodman;JJ Costanzi;AB Cruz, Jr.;VK Vaitkevicius;JD McCracken;RW Brownlee;L Laufman;RL Stephens;J Bonnet;R Bottomley;S Rivkin;W Fletcher;N Oishi;TT Chen JCO 6(6):947-954

1986

The prognosis of exophytic large bowel tumors. Data from aSouthwest Oncology Group adjuvant study and the University of ArkansasMedical Science Campus.

F Panettiere;AR Rogers ASCO :#C-306

1985

SWOG large bowel adjuvant study suggests benefits from therapy.

FJ Panettiere;TT Chen ASCO, #C-295

1984

SWOG large bowel postoperative program. An update.

FJ Panettiere;TT Chen 4th International Conference on the Adjuvant Therapy of Cancer (Tucson March 1984) 94

1983

The SWOG large bowel adjuvant program. An update.

FJ Panettiere;TT Chen ASCO #C-455

Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)

JD Boice Jr;MH Greene;JY Killen Jr;SS Ellenberg;RJ Keehn;E McFadden;TT Chen;JF Fraumeni Jr N Engl J Med 309:1079-1084

Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)

JD Boice Jr;MH Greene;JY Killen Jr;SS Ellenberg;RJ Keehn;E McFadden;TT Chen;JF Fraumeni Jr N Engl J Med 309:1079-1084

1982

The SWOG colon adjuvant study of chemotherapy with and without oral BCG: An update.

FJ Panettiere;TT Chen In: Immunotherapy of Cancer. WD Terry, SA Rosenberg, eds. New York: Elsevier-North Holland, pp. 207-215

Long-term hematologic effects of Methyl-CCNU plus 5-FU given in a Southwest Oncology Group adjuvant study.

FJ Panettiere AACR #587

1981

Letter to the Editor: IgA antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma.

FJ Panettiere Int J Cancer 27:865

Analysis of 626 patients entered on the SWOG large bowel adjuvant program.

FJ Panettiere;TT Chen In: Adjuvant Therapy of Cancer III. SE Salmon and SE Jones, eds. Grune and Stratton 539-545

Update on the Southwest Oncology Group Colorectal Adjuvant study of 620 patients.

FJ Panettiere;TT Chen ASCO #C-82

1980

The SWOG Colon Adjuvant Study of chemotherapy with and without oral BCG - an update.

FJ Panettiere;TT Chen Immunotherapy of Cancer: Present Status of Trials in Man, p.16 April

Long-term effects of chemotherapy on leukocytes of clinically healthy patients treated in accordance with the Southwest Oncology Group Colon Adjuvant Protocol.

FJ Panettiere AACR #618

Adjuvant chemotherapy with or without immunotherapy in colorectal cancer.

FJ Panettiere Clin Res 28(15)

1979

Effectiveness of post-operative adjuvant therapy with methyl-CCNU plus 5-FU with or without oral BCG in an attempt to prevent recurrence of Duke B-2 or C colon cancer. Interim report of a continuing SWOG study.

FJ Panettiere;L Heilbrun In: Adjuvant Therapy of Cancer II, Grune and Stratton, Inc., pp. 595-602

Race and chemotherapy-induced marrow suppression.

F Panettiere Clinical Research 27:745A

Are there racial differences in chemotherapy- induced leukocyte suppression.

F Panettiere AACR

Effectiveness of postoperative adjuvant therapy with Methyl CCNU + 5-FU with or without oral BCG in an attempt to prevent recurrence of Duke B2 or C Colon cancer, interim report of continuous SWOG studies.

F Panettiere;L Heilbrun International Conference on the Adjuvant Therapy of Cancer #63

1978

Postoperative adjuvant chemotherapy and immuno- therapy after total clinical resection of Duke C large bowel cancer: A Southwest Oncology Group study.

FJ Panettiere;L Heilbrun XIIth International Cancer Congress, Buenos Aires, Argentina Vol. 2:256-257

1977

Adjuvant therapy for locally advanced large bowel cancer.

FJ Panettiere In: Adjuvant Therapy of Cancer, Salmon, S.E., and Jones, S. (eds), Elsevier/North Holland, pp. 265- 272

Skin test reactivity in patients with high-risk but clinically totally resected large bowel cancer.

FJ Panettiere AACR #454

Adjuvant chemotherapy and chemoimmunotherapy for locally advanced large bowel adenocarcinoma. Preliminary report of a SWOG study.

FJ Panettiere Proc. Intl. Conference on the Adjuvant Therapy of Cancer in Tucson AZ, abst. #31